BIZ Opportunity Day Performance Q32018 Busin iness Ali lignment - - PowerPoint PPT Presentation

Opportunity Day Performance Q3’2018

Busin iness Ali lignment Public Company Li Limite ted

Date : : N November 27, , 2018

BIZ

Presentation Agenda

▪ Com

• mpany Ov

Overview ▪ Business Outlook ▪ Financial Performance ▪ Q&A

Company Overview

Com

• mpa

pany Pr Profi file

Busines siness s Al Alignm gnmen ent (BIZ) IZ) operates the distribution and installation of medical equipments for cancer treatment through radiotherapy by importing the equipments from world’s leading professional in cancer treatment equipment and technology. The company’s operations also include the maintenance service of the mentioned equipments. to being a so solut lution pr provider in cancer treatment which included providing the equipments and other related fixtures, constructing and renovating the venue to be suitable for cancer treatment for both public and private hospitals.

Maintenance

and Service

Installation

Sourcing Medical Equipment Overseeing

Construction

Survey and Design

Bri rief Company His istory

Established company Y2000 Y2006 increased its registered capital from 1 MB to 2 MB Y2014 Y2016 Y2017 Y2018 increased its registered capital from 2 MB to 5 MB

• increased its registered

capital from 5 MB to 150 MB and then to 200 MB

• Trading of BIZ on the

Market for Alternative Investment (mai) signed a project centers treating cancer patients with protons radiotherapy at King Chulalongkorn Memorial Hospital 1,200 MB

• Establishment of a

subsidiary to operate specialized hospital for cancer treatment

• Expand Business to

BIZGenes

Business Str tructure

To operate the distribution and installation

• f medical equipments for cancer treatment

To operate a hospital specializing in cancer treatment

Product and service types based on revenue type Revenue from Sales

• which comes from selling and installing the medical

equipment

Revenue from Services

• which comes from providing the maintenance service

Revenue from Construction and other Revenues

• which derived from the project to establish a cancer

patient center with proton particles and other equipment

Presentation Agenda

▪ Company Overview ▪ Business Ou Outlook ▪ Financial Performance ▪ Q&A

The World Health Organization estimates there to be a consistent increase in the number of new cancer patients each year in Thailand.

123,800 131,885 149,758 168,039 185,735 201,209 50,000 100,000 150,000 200,000 250,000 Y2012 Y2015 Y2020 Y2025 Y2030 Y2035

• No. of New Cancer Patients

Source: World Health Organization

Cancer Sta tatistic ics

Demand for Radiotherapy in Thailand

The radiotherapy delivery systems currently available in Thailand are not sufficient to provide appropriate treatment for all patients.

DEMAND

131,885 new cancer patients (2015) 50% of all cancer patients require radiotherapy (M. Samiei 2013) ~65,943 new cancer patients who required radiotherapy (2015) 400 new cancer patients can be admitted to each delivery system each year.

165 radiotherapy systems required

Current Availability

There are currently 82 radiotherapy systems in Thailand.. Of which, 20 are old technology that needs replacement.

62 up-to-date

radiotherapy systems available.

NEEDED

103

additional radiotherapy systems needed in Thailand

Srir iracha Cancer Alli lliance Hospital

CAH CAH

To operate a hospital specializing in cancer treatment between the Company and Group of physicians as a subsidiary of the Company. (Cancer Alliance Co., Ltd.) located at Nongkham sub-district, Sriracha district, Chonburi with 30 rooms for services.

The treatment can be classified into 2 main types which are 1) radiotherapy 2) chemotherapy

Pro rogress of f C Construction Sr Sriracha Cancer Alli lliance Hospital

New Business Lin ine

BIZ IZ Gen enes

“Distributor

• f

laboratory examinations and services” Genetic Test for cancer screening is an innovative test to detect genetic mutations resulting in and increased risk of cancer developing. By using the most upfront “Next Generation Sequencing Technology (NGS)”, the personalized results are highly accurate, precise and safe.

BIZ IZGenes: Press Conference

(1 (14 Nov 2018 at at Pull ullman Ban angkok Gra rande Suk ukhumvit it)

BIZ IZGenes: Press Conference

(1 (14 Nov 2018 at at Pull ullman Ban angkok Gra rande Suk ukhumvit it)

Backlog (a

(as of f 30 Sep ep 2018)

Expect recognize all revenues within year 2020

Othe Other pr proje jects ts

~1,4 ,400 mil illion Baht

1,0 1,034 mill illion Bah aht

Prot

• tons

s rad adioth therapy

36 366 mill illion Bah aht

Expect recognize all revenues within Q2’2019

Presentation Agenda

▪ Company Overview ▪ Business Outlook ▪ Fin Financial Per erformance ▪ Q&A

25.69 67.7

3Q2017 3Q2018

Gross Pr Profi fit

67.70 MB

14.56 43.02

3Q2017 3Q2018

Net Net Pr Profi fit

43.02 MB

172.24 282.71

3Q2017 3Q2018

Re Revenue

282.71 MB Million Baht

3Q18 Performance

69.3 113.13

9M2017 9M2018

Gross Pr Profi fit

113.13 MB

35.19 62.1 9M2017 9M2018

Net Net Pr Profi fit

62.10 MB

451.91 448.93

9M2017 9M2018

Re Revenue

448.93 MB Million Baht

9M18 Performance

236.71 607.12 367.61 73.83 130.72 128.28

120.66

FY15 FY16 FY17

737 37.84

+13 137.6 .60% YoY Y

• 16

16.4 .44% YoY Y

310 10.51 616 16.55

286.24 304.82 94.4 96.24 66.24 44.93

9M17 9M18 Sales of Goods Rendering of Services Construction

446.88 445.99

• 0.66%

YoY

Revenues Str tructure

Q2'18 Q3'18 Q3'17

61.70 1.70 282 82.71 172 72.24

Unit : Million Baht

Q3 Q3'1 '18 Q3 Q3'1 '17 YoY Q2 Q2'1 '18 QoQ QoQ Sale les of

• f Goo
• ods

226.79 97.54 132.51% 78.03 190.62%

Rendering of

• f Serv

ervice

33.05 33.20

• 0.43%

63.18

• 47.68%

Co Constr truction

22.88 41.50

• 44.88%

22.06 3.71%

Tota tal

282.72 172.24 87.20% 163.27 146.65%

35.19 62.1

9M2017 9M2018

Gros Gross s Pro rofit fit

9M2017 9M2018

14.56 43.02

Q3'2017 Q3'2018

FY15 FY16 FY17

Million Baht 23.95% 14.92%

24.75% 15.34% 15.77% 16.62% 13.90%

Net et Profi rofit

20.79 70.24 41.15

FY15 FY16 FY17

Million Baht 15.17% 8.42%

13.83%

7.79% 6.52% 9.45% 6.60%

14.56 43.02

3Q2017 3Q2018

FS S Company

Financial ratio

ROE (% (%) D/E Rat atio io (tim (time)

9.05% 18.72% 8.04% 7.05% 12.54% 2015 2016 2017 9M17 9M18 0.56 0.23 0.5 0.69 0.62 2015 2016 2017 9M17 9M18

Presentation Agenda

▪ Company Overview ▪ Business Outlook ▪ Financial Performance ▪ Q& Q&A

Q& Q&A

THANKS!

Business Alignment Public Co., Ltd. 92/45 Sathorn Thani Building 2, 16th Floor, North Sathorn Rd., Bangrak, Bangkok 10500 Tel: 02-636-6828-9 Fax: 02-236-3167 Website: www.bizalignment.com e-mail: ir@bizalignment.com